"Designing Growth Strategies is in our DNA"
The global electronic case reporting (eCR) market size was valued at USD 0.7 billion in 2024 and is projected to reach USD 1.8 billion by 2032, exhibiting a CAGR of 12.5% during the forecast period.
Electronic case reporting (eCR) is the automated exchange of case report information between healthcare facilities and public health agencies. These eCR applications facilitate effective disease tracking, case management, and contact tracing. The rapid adoption of these eCRs is important as they help public health agencies and healthcare providers detect outbreaks earlier, target interventions to high-risk populations, plan for capacity and resources, and support long-term population health planning. These factors are expected to drive market growth.
Such critical applications of the market are encouraging various public health entities to adopt these solutions, boosting market growth.
Highlighted Importance of eCR in Pandemic Readiness and Ongoing Infectious Disease Threats
One of the key factors driving the growth of the market is the ease of adoption of these solutions after the COVID-19 pandemic. The pandemic highlighted the importance of crisis readiness and facilitated the adoption of measures for other ongoing infectious disease threats. Health systems are actively funding electronic case reporting to identify new disease clusters early, monitor variants and emerging threats in real-time, and coordinate responses across regions. This shift from crisis-driven spending to strategic investment directly supports sustainable, long-term growth for the eCR market.
Download Free sample to learn more about this report.
In November 2022, Journal of Clinical and Translational Science published an article titled ‘Evaluating Automated Electronic Case Report Form Data Entry from Electronic Health Records’ that reported both a study coordinator and a data analyst agreed that 152 (78%) instances were a result of data entry error. This error could be reduced with EHR and electronic case reporting integration.
Limited eCR adoption to Hamper Market Growth
The limited adoption of eCR acts as a key restraint for the market, as it prevents the market from reaching its full potential and limits growth to its maximum value. The market witnessed variability in eCR adoption, with large health systems and urban hospitals moving ahead, while many smaller and independent providers still lack the IT capacity, funding, or motivation to implement eCR. This creates a disparity where public health agencies get high-quality electronic data from some facilities but still rely on manual reporting from others. These factors weaken the surveillance as gaps in adoption result in blind spots in disease monitoring, hampering the market growth.
Automations with Advancement in Technology to Facilitate Utilization and Offer Lucrative Growth Opportunities
Automations in eCR solutions, driven by technological advancements, offer a lucrative growth opportunity for the market. They facilitate adoption with easy to use interface and reduce time, scale, and maintain for both providers and public health agencies. As artificial intelligence and natural language processing tools mature, they can automate menial tasks such as clean up documentation, reducing false alerts, and auto-filling missing fields, which directly improves data quality and user trust. This shift can deploy faster, support more customers with the same resources, and offer higher-value services. Additionally, new product launches with integrated tools support market growth.
Such developments are expected to boost the growth of the market.
|
By Product |
By Deployment |
By End User |
By Geography |
|
· EHR-integrated eCR modules · Public-health disease surveillance platforms · HIE/interoperability middleware · eCR gateways/compliance tools |
· On-Premise / Hybrid · Cloud Based |
· Healthcare Providers · Public Health Agencies · Reference Labs & Commercial Labs · Others |
· North America (U.S. and Canada) · Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific) · Latin America (Brazil, Mexico, and the Rest of Latin America) · Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa) |
The report covers the following key insights:
Based on product, the market is subdivided into EHR-integrated eCR modules, public-health disease surveillance platforms, HIE / interoperability middleware, and eCR gateways / compliance tools.
The EHR-integrated eCR module segment is expected to dominate the global electronic case reporting (eCR) market. The dominance of these solutions is due to wide adoption in hospital EHRs. The bundling of eCR with EHR drives segmental growth. Regulatory and public health programs mandate automated case reporting, further increasing the demand for integrated modules. As a result, EHR-integrated eCR modules capture the largest share in the ecosystem. Further, the market is anticipated to grow with key product launches.
Based on deployment, the market is bifurcated into on-premise / hybrid and cloud based.
The cloud-based segment is estimated to dominate the market during the forecast period. The segment's dominance is attributed to the increasing adoption by hospitals and the cost-effectiveness offered by these solutions compared to others. The lower upfront capital cost and subscription pricing make cloud-based eCR far easier to adopt. Various public health funding programs prefer these cloud-based solutions as they are quicker to deploy and easier to secure at scale. These advantages encourage key companies to direct their resources toward new product launches further.
Based on end user, the market is fragmented into healthcare providers, public health agencies, reference labs & commercial labs, and others.
The healthcare providers segment dominated the global market share as they are the first point of contact for case report originators. The increasing adoption of eCR-integrated EHR modules by healthcare providers, such as hospitals, drives segmental growth.
Request for Customization to gain extensive market insights.
By region, the market has been studied across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
North America accounted for approximately 60% of the global electronic case reporting (eCR) market in 2024. The dominance of the region is due to strong regulatory support and mature EHR adoption across hospitals and clinics. The region has a robust eCR infrastructure. Additionally, increasing healthcare expenditure in the region is expected to reinforce its dominance. These factors have also prompted key companies to focus on strategic collaborations and acquisitions to cater to the increasing demand in the region.
Europe is expected to hold a substantial share of the global electronic case reporting (eCR) market. The high market share of the region is due to increasing investment in the region and rising adoption of EHR systems. Regional authorities in Europe are tightening infectious disease monitoring and promoting real-time data sharing, transitioning from fax- or form-based reporting to structured electronic workflows. These factors are likely to drive the growth of the regional market.
Asia Pacific is expected to grow with a significant CAGR during the forecast period. The growth in the region is attributed to increasing investment in digital disease surveillance capacity in these emerging economies. Many countries in the region are deploying cloud-based surveillance platforms and national health information exchanges with case reporting functions. Furthermore, the collaboration of major tech vendors and cloud providers with ministries of health offers growth opportunities.
The global electronic case reporting (eCR) market is semi-fragmented with the presence of a few groups and a large number of emerging companies.
The report includes the profiles of the following key players:
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )